Amicus Therapeutics Upgraded To Outperform; Overhangs Are Removed With Catalysts Ahead
January 24, 2017 at 10:25 AM EST
Baird has upgraded Amicus Therapeutics, Inc. (NASDAQ: FOLD) to Outperform, driven by the removal of two key overhangs in the form of ...
